Digital Ask NAVLIN: The AI chatbot innovation driving a better globa... Demonstrating EVERSANA’s commitment to innovation, a new artificial intelligence technology aims to improve NAVLIN for both existing and new customers.
News Neurogene drops high-dose arm in Rett study after death The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends